|
|
|
| Application of task form health management strategy in asthmatic children treated with continuous inhaled glucocorticoids |
| HA Haixia LUO Yongli▲ YANG Guanshan |
| Department of Pediatrics, Ankang Hospital of Traditional Chinese Medicine, Shaanxi Province, Ankang 725000, China |
|
|
|
|
Abstract Objective To explore the effect of task form health management strategy on compliance and clinical efficacy of asthmatic children treated with continuous inhaled glucocorticoids. Methods 84 children with asthma treated in Ankang Hospital of Traditional Chinese Medicine were divided into two groups according to the time of admission. Among them, 41 children who were treated from July to December 2015 were selected as the routine group, and the traditional nursing education program was adopted. 43 children treated from January to June 2016 were selected as intervention group, and the task form and health management strategy were adopted to intervene. The medication compliance, clinical symptom score and pulmonary function before and 3, 6, 12 months after the intervention of the two groups were compared. Results Comparison within the same group, compared with before intervention, the medication compliance scores, peak expiratory flow rate measured values of percentage of predicted value (PEF%) and forced expiratory volume in the first second percentage of predicted value (FEV1%) of the intervention group after 3, 6 and 12 months of intervention significantly increased (P < 0.05), the clinical symptom scores significantly decreased (P < 0.05). Compared with before intervention, the medication compliance scores of routine group after 6 and 12 months of intervention significantly decreased (P < 0.05), PEF% and FEV1% significantly improved after intervention (P < 0.05), the clinical symptom scores after 3, 6 and 12 months of intervention significantly decreased (P < 0.05). Comparison between groups, after 3, 6 and 12 months of intervention the medication compliance scores and PEF% of the intervention group were significantly higher than those of the routine group (P < 0.01); after 6 and 12 months of intervention the clinical symptom scores of the intervention group were significantly lower than those of the routine group (P < 0.01), and the FEV1% values were significantly higher than those of the routine group (P < 0.05). Conclusion The task form health management strategy can effectively improve the compliance of asthmatic children treated with continuous inhaled glucocorticoids, reduce the clinical symptoms and improve the lung function.
|
|
|
|
|
|
[1] 全国儿科哮喘协作组.第三次中国城市儿童哮喘流行病学调查[J].中华儿科杂志，2013，51（10）：729-735.
[2] Papadopoulos NG，Arakawa H，Carlsen KH，et al. International consensus on（ICON）pediatric asthma [J]. Allergy，2012，67（8）：976-997.
[3] Masoli M，Fabian D，Holt S，et al. Global Initiative for Asthma（GINA）Program：Global Burden of Asthma [EB/OL]. （2014-08-20）[2016-03-20]. http：//www.ginasthma.org/local/uploads/files/GINABurdenReport_1.pdf.
[4] 张冉，田庆秀，姚丽娜，等.支气管哮喘患者糖皮质激素吸入技术的评价[J].中华护理杂志，2015，50（8）：975-980.
[5] 张惠蓉，阴崇娟.延续性护理模式对支气管哮喘患儿生活质量的影响[J].护理研究，2015，29（12）：4604-4605.
[6] 中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南（2016年版）[J].中华儿科杂志，2016，54（3）：167-181.
[7] 田庆秀，余丽君.中文版支气管哮喘用药依从性量表的信效度检验[J].中华护理杂志，2014，49（5）：621-624.
[8] 秦琼，陈蓉，雷伟，等.哮喘、慢性阻塞性肺疾病患者吸入给药装置依从性评价与分析[J].中国药学杂志，2016，51（5）：413-416.
[9] 周佳丽，张芬，杨丽，等.哮喘儿童吸入性糖皮质激素治疗依从性研究进展[J].中国实用护理杂志，2017，33（10）：787-790.
[10] 马旭升，涂林修，梅依君，等.儿童哮喘规范化管理治疗效果评价[J].临床儿科杂志，2015，33（8）：706-709.
[11] Peláez S，Lamontagne AJ，Collin J，et al. Patients′ perspective of barriers and facilitators to taking long-term controller medication for asthma：a novel taxonomy [J]. BMC Pulmonary Medicine，2015，15（1）：42.
[12] 李林蔚，黄英，罗蓉，等.规范或间断吸入糖皮质激素对哮喘患儿疗效及生长发育的影响[J].中国当代儿科杂志，2015，17（3）：237-240.
[13] 杨婷，饶花平，金世杰，等.吸入型糖皮质激素对急性哮喘发作患儿的疗效研究[J].中国医药，2015，10（6）：809-811.
[14] 刘艳明，农光民，李树全.轻-中度哮喘患儿气道炎症类型与病情、糖皮质激素疗效的关系[J].临床儿科杂志，2010，28（2）：145-149.
[15] Szefler SJ，Lars-Goran C，Tom U，et al. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma [J]. Journal of Allergy & Clinical Immunology in Practice，2013，1（1）：58-64.
[16] 刘广杰，胥杰，罗秀芳.布地奈德吸入剂及其联合口服缓释茶碱治疗支气管哮喘的效果[J].中国医药导报，2015， 6（18）：12-15.
[17] 张晓丽，王学梅.吸入布地奈德联合盐酸西替利嗪和/或孟鲁司特钠治疗儿童过敏性鼻炎-哮喘综合征的效果对比[J].中国医药导报，2016，13（18）：117-121.
[18] 张伟新，郝春艳.加温压缩雾化器对老年支气管哮喘病人的影响[J].护理研究，2014，28（3）：327-328.
[19] 关景超.积极护理干预系统在哮喘患儿糖皮质激素吸入护理中的应用[J].国际护理学杂志，2017，36（1）：44-46.
[20] 林友青，王炳秋，庄城林，等.小儿哮喘教育管理[J].中国医药科学，2015，5（2）：124-126.
[21] 中国哮喘儿童家长知信行调查项目组.中国大陆29个城市哮喘患儿病情控制状况及影响因素[J].中华儿科杂志，2013，51（2）：90-95.
[22] 涂江美.综合护理干预在小儿支气管哮喘治疗中的应用效果分析[J].中国医药科学，2015，5（1）：150-152. |
|
|
|
